Joseph Jacob, MD
Urology · Syracuse, NYNPI 1235440090
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $30,180 of the $39,264 with a category attached, or 76.9%. 9 manufacturers reported payments, led by Urogen Pharma, Inc. at 26.1% of the total. Reporting peaked in 2022 at $18,496 and has fallen 82.7% since, to $3,200 in 2025. Among urology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 47 payments — averaging $835.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Urogen Pharma, Inc.$10K
- Janssen Scientific Affairs, LLC$9K
- Janssen Research & Development, LLC$6K
- Photocure Inc$5K
- Pfizer$4K
- Janssen Global Services, LLC$2K
- plus $2K from 3 others
Across 109 payments — averaging $9106.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$855K
- Merck$96K
- Ferring Pharmaceuticals AS$28K
- Urogen Pharma, Inc.$14K
What the payments were for
- Consulting fees$30,18077%
- Speaking & faculty fees$3,1008%
- Travel & lodging$4,48611%
- Food & beverage$1,3984%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Urogen Pharma, Inc. | 6 | $10,230 |
| Janssen Scientific Affairs, LLC | 17 | $9,151 |
| Janssen Research & Development, LLC | 7 | $6,174 |
| Photocure Inc | 5 | $5,260 |
| Pfizer | 4 | $4,327 |
| Janssen Global Services, LLC | 2 | $2,165 |
| Verity Pharmaceuticals Inc. | 1 | $1,600 |
| Myovant Sciences Inc. | 4 | $258 |
| AVEO Pharmaceuticals, Inc. | 1 | $99 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$39,264 in reported general payments places this provider in the 90th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 19 | $11,346 |
| Tamsulosin Hcl | 249 | $2,596 |
| Finasteride | 54 | $844 |
| Oxybutynin Chloride ErOxybutynin Chloride | 18 | $619 |
| Methenamine Hippurate | 13 | $543 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 51 | $237 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 16 | $206 |
| Ciprofloxacin Hcl | 13 | $51 |
| Cephalexin | 15 | $32 |
| Tramadol Hcl | 20 | $19 |
Paid to pharmacies, not to this prescriber.
Other urology in Syracuse
- Christopher PieczonkaSyracuse$797K
- David AlbalaSyracuse$139K
- Andrew StephensonSyracuse$95K
- Po LamSyracuse$81K
- Peter WalterJamestown$1.9M
- Bilal ChughtaiNew York$658K
- Katie MurrayNew York$575K
- Neil BanderNew York$544K
- Robert ValenzuelaNew York$494K
- Jeffrey SpencerCheektowaga$430K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.